A Phase IB/II Trial of Combination of Vinorelbine With Sorafenib (BAY 43-9006) as First-Line Treatment in Patients With Metastatic Breast Cancer.
Phase of Trial: Phase I/II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Sorafenib; Vinorelbine
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 18 Oct 2008 New trial record.